title: The efficacy of thalidomide in severe refractory seronegative spondylarthropathy: comment on the letter by Breban et al.
authors.forename: L
authors.initials: L
authors.lastname: Lee
authors.forename: R
authors.initials: R
authors.lastname: Lawford
authors.forename: H P
authors.initials: HP
authors.lastname: McNeil
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000503:physiopathology; D013792:Thalidomide / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D013792:Thalidomide